China Aoxing Pharmaceutical Co Inc. (CAXG.OB)
Loading...
Symbols:
CAXG.OB Forum Topics
Recent CAXG.OB Articles
- American Oriental Sets Sights on Being China's Biggest Pharma
- Biotech in Review: Positive Consolidation in China Life Science Companies
- American Oriental Still Intent on Expansion: Buys Stake in China Aoxing
- Earnings and More in China Biotech Weekly Review
- China Aoxing to Buy Traditional Chinese Medicine Company
- Aoxing Pharmaceutical's Anti-Opioid Addiction Drug Approved by China’s FDA
- Biotech Week in Review: Cross Border China Pharma Activity
- China Aoxing Receives Manufacturing Exclusivity for Cancer Pain Drug
- China Aoxing Granted License for Addiction Drug, Still Lacks Firm Financial Footing
- China Aoxing Begins Trial for Opioid Pain Drug
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
sion
Biotech in Review: Positive Consolidation in China Life Science Companies [view article]
I disagree with jturano, GNBT already has approval in India and some South American countries and will start sales. being in phase III is for the U.S and Canada and they have a proven product. Though there is some competition still working on products, some of the big pharmas have failed. Is the U.S. the only market in the world? NO and Generex should get their approvals. SciGen made a joint venture in essentially 2006. They are making a plant to produce insulin which Generex can obtain elsewhere if needed. ReplyBiotech in Review: Positive Consolidation in China Life Science Companies [view article]
Although SciGen does not currently market products in China, SciGen and Hefei Life Science & Technology Investments established a China joint venture in December 2005. The JV is building a $30 million manufacturing facility for Sci-B-Vac, SciGen’s hepatitis B vaccine.BOTTOM LINE, THEY ARE STILL BUILDING A FACILITY SINCE 2005. ORA-LYN IN PHASE 3,
WHAT'S THIS MEAN FOR SHAREHOLDERS?
OPPORTUNITY TO GET OUT ON NEWS IF THE STOCK GOES UP.
REALITY IS GNBT WON'T BECOME A STAR OVERNIGHT OR GO IN THE BLACK.
IT ONLY MAKES SHAREHOLDERS BECOME MORE HYPED ON THE COMPANY BUT DO NOT MAKE THEM RICHER BY NO MEANS! Reply
American Oriental Still Intent on Expansion: Buys Stake in China Aoxing [view article]
I like AOB also. Sold it awhile back for profit. % of short sellers to high. AOB has greatfundamentals. Cash Cow growing by acquisitions and now in "drug" biz with CAXG.OB and
Shijiazhuang. CAXG.OB needs to deliver and i'll be watching!! From Wealth Builder.
On Apr 17 06:32 PM Ikaris wrote:
> Just bought some (100) of these shares because it sounded like they
> had a lot of potential. It really seems to be a strange transaction
> they just entered into with Aoxing; they purchased the shares at
> a discount and it went up as a result (your math on the shares is
> wrong by the way)? Does that not sound a little weird? What would
> they do in the US if that kind of transaction happened? Reply
American Oriental Still Intent on Expansion: Buys Stake in China Aoxing [view article]
Just bought some (100) of these shares because it sounded like they had a lot of potential. It really seems to be a strange transaction they just entered into with Aoxing; they purchased the shares at a discount and it went up as a result (your math on the shares is wrong by the way)? Does that not sound a little weird? What would they do in the US if that kind of transaction happened? ReplyEditors
General Discussion on CAXG.OB
Is this a buy or a sell? Reply